EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Retinal Biomarkers in Diabetic Retinopathy: From Early Detection to Personalized Treatment

Georgios Chondrozoumakis iD, Eleftherios Chatzimichail iD, Oussama Habra, Efstathios Vounotrypidis iD, Nikolaos Papanas iD, Zisis Gatzioufas, Georgios D Panos iD

Journal of Clinical Medicine · 18.02.2025 · 14 (4) · 1343

DOI: 10.3390/jcm14041343 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Clinical Medicine, online erschienen am 18.02.2025. Verfasst von Georgios Chondrozoumakis und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ophthalmology, University Hospital of Heraklion, 71500 Heraklion, Greece. Die Arbeit wurde bisher 29-mal zitiert (Crossref) und nennt 141 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Diabetic retinopathy (DR) is a leading cause of vision loss globally, with early detection and intervention critical to preventing severe outcomes. This narrative review examines the role of retinal biomarkers—molecular and imaging—in improving early diagnosis, tracking disease progression, and advancing personalized treatment for DR. Key biomarkers, such as inflammatory and metabolic markers, imaging findings from optical coherence tomography and fluorescence angiography and genetic markers, provide insights into disease mechanisms, help predict progression, and monitor responses to treatments, like anti-VEGF and corticosteroids. While challenges in standardization and clinical integration remain, these biomarkers hold promise for a precision medicine approach that could transform DR management through early, individualized care.

Schlagwörter

Stichwörter der Autor:innen

biomarkersdiabetesdiabetes complicationsdiabetic retinopathyophthalmologyretinal biomarkersretinal imaging

Autor:innen und Institutionen

  • Department of Ophthalmology, University Hospital of Heraklion, 71500 Heraklion, Greece.
  • Department of Ophthalmology, University Hospital of Basel, 4031 Basel, Switzerland.
  • Department of Ophthalmology, Ulm University, Prittwitzstraße 43, 89075 Ulm, Germany.
  • Diabetes Centre, Second Department of Internal Medicine, Democritus University of Thrace, 68100 Alexandroupolis, Greece.
  • First Department of Ophthalmology, AHEPA University Hospital, School of Medicine, Aristotle University of Thessaloniki, 54124 Thessaloniki, Greece.
  • Division of Ophthalmology & Visual Sciences, School of Medicine, University of Nottingham, Nottingham NG7 2UH, UK.

ORCID-Profile: Georgios Chondrozoumakis, Eleftherios Chatzimichail, Efstathios Vounotrypidis, Nikolaos Papanas, Georgios D Panos

Zitieren

APA

Chondrozoumakis, G., Chatzimichail, E., Habra, O., Vounotrypidis, E., Papanas, N., Gatzioufas, Z., & Panos, G. D. (2025). Retinal Biomarkers in Diabetic Retinopathy: From Early Detection to Personalized Treatment. Journal of Clinical Medicine, 14(4), 1343. https://doi.org/10.3390/jcm14041343

Vancouver

Chondrozoumakis G, Chatzimichail E, Habra O, Vounotrypidis E, Papanas N, Gatzioufas Z, et al. Retinal Biomarkers in Diabetic Retinopathy: From Early Detection to Personalized Treatment. Journal of Clinical Medicine. 2025;14(4):1343. doi:10.3390/jcm14041343

BibTeX
@article{Chondrozoumakis2025,
  author = {Chondrozoumakis, Georgios and Chatzimichail, Eleftherios and Habra, Oussama and Vounotrypidis, Efstathios and Papanas, Nikolaos and Gatzioufas, Zisis and Panos, Georgios D},
  title = {Retinal Biomarkers in Diabetic Retinopathy: From Early Detection to Personalized Treatment},
  journal = {Journal of Clinical Medicine},
  year = {2025},
  volume = {14},
  number = {4},
  pages = {1343},
  doi = {10.3390/jcm14041343}
}
Kostenlos starten →